Oncofetal chondroitin sulfate in cancer therapy: a promising target for anti-tumor drug delivery?

Elena Ethel Vidal-Calvo; Ali Salanti

doi:10.1080/17425247.2025.2606747

Oncofetal chondroitin sulfate in cancer therapy: a promising target for anti-tumor drug delivery?

Expert Opin Drug Deliv. 2025 Dec 31:1-6. doi: 10.1080/17425247.2025.2606747. Online ahead of print.

Authors

Elena Ethel Vidal-Calvo¹, Ali Salanti^{1

2}

Affiliations

¹ Centre for Translational Medicine and Parasitology, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
² VAR2 Pharmaceuticals, Frederiksberg, Denmark.

PMID: 41412154
DOI: 10.1080/17425247.2025.2606747

No abstract available

Keywords: Antibody-based therapy; Cabohydrates; Tumor microenvironment; Tumor stroma; cancer; chondroitin sulfate; oncofetal; sulfate, tumor-associated.

Publication types

Editorial